Antibiotic Loaded Nano Rod Bone Cement for the Treatment of Osteomyelitis

Mala Rajendran1, Gazana Iraivan1, Ghayathri B L1

  • 1Department of Biotechnology, Mepco Schlenk Engineering College, Sivakasi-626005, Tamil Nadu, India.

Abstract

Insights

Biodegradable nano-hydroxyapatite offers a sustained 8-week antibiotic release for osteomyelitis treatment, outperforming traditional polymethyl methacrylate (PMMA) bone cement. This advanced material provides a promising alternative for local antibiotic therapy.

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Drug Delivery Systems

Background:

  • Polymethyl Methacrylate (PMMA) bone cement is standard for osteomyelitis but has limitations: rapid antibiotic release (50% in 3 days), heat generation, and non-biodegradability requiring removal surgery.
  • Hydroxyapatite is a known alternative to PMMA for bone regeneration and drug delivery.

Purpose of the Study:

  • Synthesize biodegradable nano-hydroxyapatite for slow and sustained antibiotic release.
  • Investigate the release kinetics of antibiotics from nano-hydroxyapatite.

Main Methods:

  • Nano-hydroxyapatite synthesized via co-precipitation and characterized using particle size analysis, TEM, FTIR, and EDX.
  • Antibiotic-loaded nano-hydroxyapatite beads (7 mm) prepared and tested for antibacterial efficacy using well diffusion assay.
  • Antibiotic release kinetics fitted to zero-order, first-order, second-order, Higuchi, Korsmeyer-Peppas, and Gompertz models.

Main Results:

  • Synthesized nano-hydroxyapatite averaged 5 nm in size.
  • Antibiotic-loaded nano-hydroxyapatite demonstrated therapeutic efficacy for 8 weeks, compared to 10 days for micro-sized hydroxyapatite, indicating sustained release.
  • The Korsmeyer-Peppas model best described the antibiotic release kinetics from nano-hydroxyapatite.

Conclusions:

  • Nano-hydroxyapatite with a Ca/P ratio of 1.78 is effective for sustained antibiotic delivery over 8 weeks.
  • This nano-hydroxyapatite formulation presents a superior alternative to PMMA for treating osteomyelitis with prolonged local antibiotic therapy.

Related Concept Videos